Beyond the milestone in transplantation represented by the introduction of cyclosporine as an immunosuppressant, other factors have continued to operate to enhance survival rates for liver recipients. Previous studies have stressed the importance of venous bypass, I the proper use of retransplantation,2 and refinements in the use of cyclosporine along with antilymphocyte preparations in effecting these additional improvements. 3 Each of these factors is reviewed in detail elsewhere in this issue of Seminars.
At the same time. better overall survival rates have served to underscore the need to develop criteria that might aid in defining a population of patients upon whom the effects of better immunosuppression and better technique have had little or no impact. The purpose of the present study is to determine whether an assessment of certain recognizable and measurable patient characteristics might aid in predicting survival (Fig. I ). More specifically, the primary interest is to elucidate those factors other than rejection itself or technical failures that 'eriously hinder survival. Only adults will be conered. since a preliminary examination of data su ~ested that such preoperative patient characterare much less important in predicting survival amo children. Only 6-month survival will be examin"d because the few patients who die after that daO seldom die from causes related to their 
METHODS
A total of 160 adult patients received primary, orthotopic liver transplantation at the University of Pittsburgh Health Center between July I. 1981. and December 31, 1984. Of these. 3S eventually required retransplantation and seven were considered operative deaths. For survival calculations, only those 118 patients surviving at least 1 day and not requiring more than one graft were included. For consideration of factors that influence blood loss during the first transplant operation. all 160 patients were included.
Clinical Variables
Patient variables considered included age. diagnosis. race, sex. date of transplantation, number of transplants, duration of survival, measurements of serum bilirubin. creatinine, albumin. and the prothrombin time. All patients were given scores (based on a retrospective review of their preoperative records) in the following categories:
1. Coma (COMA): A score of 2 was assigned for those patients experiencing episodes of stage 3 or 4 coma; a score of I, for those with intermittent episodes of moderate to severe confusion or fre· quent problems with mild to moderate confusion;
and a score of O. for those with no gross evidence of encephalopathy.
Malnutrition (MAlN):
A score of 2 was assigned for those with severe muscle wasting and obvious evidence of generalized malnutrition; a score of 1. for those with less severe malnutrition; and a score of 0 for those with no obvious signs of poor nutrition. 3. Ascites (ASCI): A score of 2 was assigned for those with massive, uncontrollable ascites; a score of I, for those with moderate or controllable ascites; and a score of 0, for those with no evidence of ascites.
Miscellaneous:
If a history of recurrent variceal bleeding, biliary sepsis, or spontaneous bacterial peritonitis, was present, a score of I was assigned, 0 if absent.
Previous Surgery:
In addition, each patient was assigned an index of previous operative procedures (lOP), which was an additive score as follows: multiple previous biliary reconstructions, 2; and a single attempt, 1; portosystemic shunt procedure, 2; splenectomy, open liver biopsy, cholecystectomy, or other procedures in the upper abdomen, 1 for each separate laparotomy.
Operative blood losses (RBC) were determined by a review of the records of the Central Blood Bank of Pittsburgh and are expressed in terms of the units of packed red blood cells administered to the patient during the transplant operation.
Statistical Methods
Complete survival data were available for all patients to 6 months. Life-table analysis was used to calculate survival probabilities for intervals beyond 6 months. Multiple linear regression was used initially to examine the effects of the different variables on 6-month survival. Simple two-way linear regression was used to examine the isolated effect of each variable on survival and on RBC.
,a L Unpaired sample means \\lCrl' compared u\inf the unpaired I test, and propor on' compared with the chi-square test, using Vat correction when inditated. Risk ratios, which are n estimate of the relative risk associated with a var ble. were calculated for different score groups an 511:'0 confidence intervals were calculated using the st ndard error of the risk ratio.
Disease Scoring System
Finally, a disease scoring system was vel oped based on an examination of those facto most often associated with an eventual poor ou orne. The scoring system was extensively modified b) rial and error to allow a maximum separation bet" n those patients who survived for 6 months and thl. who did not. Table 1 shows the results of a simple two-way analysis of the variables using linear regression. Survival at 6 months was found to correlate inversely and to a significant degree (see p values in Table  I ) with RBC, COMA, MALN, bilirubin, and prothrombin time, and directly with the date of the transplant operation. It did not correlate to a significant degree with the patients' age, sex, race, or diagnosis, or with lOP or ASCI scores. Stepwise multiple linear regression analysis revealed RBC to have the highest inverse correlation with survival (p < 0.0001), followed by COMA (p = 0.0001). However, because of multicolinearity. the addition to the equation of the remaining scores of disease severity did not improve the correlation. Further work with various combinations of COMA, ASCI, and MALN scores revealed the best inverse correla- An examination of the various values of R 2 (R = correlation coefficient) for the different regressions revealed that most were less than 10070. This suggests that a linear model is not appropriate for defining the relationship between the variables. In fact, in a scatterplot of different variables on the X axis versus survival probabilities on the Y axis, the curves defined for each metric variable (such as bilirubin levels, RBC. or prothrombin times) were sigmoid in shape (Fig. 1 ). This suggests that the relationship between survival and many of these patient variables might best be described by a third
RESULTS
An examination of the sigmoid curve in Figure  1 demonstrates how the probability of survival falls off sharply at a certain value of each patient variable. This observation was the basis for constructing a disease scoring system that would allow one to place patients into one of the three groups delineated by the two inflection points along the sigmoid curve. Those with a disease score in the flat, upper left part of the curve would represent relatively lowrisk patients, and those in the flat portion of the lower right section of the curve would clearly be high-risk patients. Those patients with scores placing them between the inflection points of the curve would represent a group for whom the relative risks for transplantation would be difficult to estimate, since small errors in scoring (motion along the X axis in Figure 1 ) would drastically alter estimates of survival probability (position along the Y axis).
Development of the Disease Scoring System
The scoring procedure developed was that which proved most useful in defining a clear separation between the highest and lowest risk groups. This was accomplished mainly by trial and error. During this process, patients who had low-risk scores but died from causes related to surgical or immunologic factors and not to their preexisting liver disease were eliminated from consideration. This represented 7 of the 22 patients who died by 6 months. They are listed in Table 4 along with the causes of death.
The disease score is determined by adding the COMA. MALN, and ASCI scores together, with the following modifications: (l) I f the patient is in a deep coma at the time of going to the operating room for the transplant, the COMA score is increased to 6; (2) an additional I point is given if the patient'<; age is more than 40 years; (3) 2 additional poinrs are 1!i\l.~n if the serum bilirubin level is higher than 30 mg/dl: (4) I point is subtracted if the prothrombin time is less than 15 seconds; (5) an additional I point is subtracted if the bilirubin level is less than 10 mg/dl; (6) if the resulting score is 5 or greater. 2 points should be subtracted if the patient's age is less than 25 years; and (7) the marked effect on survival of the RBe is accounted for as follows: for patients with a total score of 5 or more, ,t point can be subtracted if RBC is 10 units or less; l~r all patients, if RBC is 40 units or more. an additi 'al I point should be added to the total score. Patients with a resultant score of 0 to 3 represent 'Iatively low-risk patients. Those with a 'Score of 7 0' more are at high risk. Those with scores from ~ to 6 are located between the inflection points 0 Ihe sigmoid curve and thus represent pa-I iC!'nts wh e relative risks are difficult to estimate.
F RETROSPECTIVE SCORING .
The mC!'an ~ore of those patients who died by 6 1ll\IJllh .. (~'~~rt '-hose patients listed in 
Causes of Death After 6 Months
Eight of the 96 patients who survived 6 months subsequently died during the follow-up period. Recurrence of tumor was the cause of death in four of these patients (all whose disease scores were 1 or 0), at intervals of 265, 480, 490, and 617 days after transplantation. Two men, ages 53 and 38 years with scores of 0 and 2, died in foreign countries, at 426 and 90S days, respectively, of causes that were unclear but thought to be of cardiac origin. A fifth patient, a 44-year-old man whose preoperative score would have been 7. died after 439 days with hepatic failure and sepsis related to recurrent hepatitis B.
Finally, a 20-year-old man, (disease score = 3), died 339 days postoperatively following massive gastrointestinal hemorrhage.
High-Risk Patients Surviving
More Than 6 Months Only 2 of the 96 patients who survived beyond 6 months had scores in the high-risk range. One was a 45-year-old woman with primary biliary cirrhosis who is a remarkable exception to the rule. Her preoperative score would have been 9. The second patient was the 44-year-old man mentioned in the preceding discussion. Both patients required extended rehabilatation periods, particularly the woman.
Five other patients had preliminary scores ranging from 5 to 8 that were reduced by 2 points because of ages less than 25 years. All are alive and well after recovery periods [hat were relatively short when compared with Ihe group of older patients with scores of 6 to 9. This experience is the basis for 
Low-Risk Patients Surviving Less Than 6 Months
Besides the exceptions listed in Table 4 , two other patients who died in less than 6 months had scores of 0 and 3. One was a 19-year-old girl who died of disseminated herpes zoster, and the other was a 52-year-old woman who required mUltiple surgical reexplorations for intra-abdominal bleeding and sepsis.
Patients with Scores Between the Inflection Points
Five patients who did not survive at least 6 months and 14 who did had scores between 4 and 6. One of those who died had a score of 8 before reduction to 6 for an age of 18 years. Death in two was related to opportunistic infection arising at I and 4 months following discharge, most likely related to overimmunosuppression. Two others died largely a,s the result of surgical complications.
Three of the surviving patients (with scores of 5, 5, and 4), required prolonged hospitalization (4 months to more than I year) for rehabilitation and for treatment of various surgical complications. The others experienced rather uneventful recoveries that were free of surgical complications.
Scoring of Retransplanted Patients
A group of 33 out of 35 patients who required retransplantation were scored subsequent to development of the system (Table 5 ). (Two patients were eliminated from consideration because they underwent transplantation using venous bypass with full systemic heparinization.) Four of these patients required three transplants, of whom two are still alive at 2 and 3 years. Blood loss at the first transplant operation only was considered for scoring purposes. Coma scores were given on the basis of mental status at the lime of reoperali(lO All nther \ariat-Ic, were scored on the basis of their,\aluc:\ prinr tn Ihe first transplant operation.
"mong the 18 retransplanted atients who died within 6 months of the first tran. lant operation. scores ranged from 6 to 12, with t e exception of one patient with a score of O. That p tient died 176 days after the first transplant from a Ie colchicine toxicity. The mean score of the rema ,ing 17 pa· tients was 9.2 ± 1.8). The major facto:· contribut· ing to high scores for 16 of these patient was thai of coma scores of 6, indicating stage III ot W coma at the time of retransplantation.
Of the remaining 15 patients who were re amplanted, 14 are alive from 14 to 43 months fOI wing their first transplant. The one patient who had an arterial thrombosis in the second graft ar. was not transplanted a third time. Scores in this group ranged from 0 to 6, with a mean of 2.3 ± 1.7). None of these patients were in a coma at the time of retransplantation, although four were retransplanted urgently, two for accelerated acute rejection and two for primary nonfunction. 2 Table 6 summarizes the scoring for those III patients used in developing the disease scoring system. Relative risk ratios were calculated from a chi-square table (with Yates correction when indicated) and 95070 confidence limits estimated. A score of 7 or higher carries a 41 (95070 confidence range 7.29 to 231) times greater risk of dying within the first 6 months following transplantation than does a lower score. The risk ratios and confidence limits for other scores, along with chi-square values. are shown in Table 6 . Another way of interpreting each ratio is to use the inverse argument. Thus, not only are patients with a score of 7 or higher 41 times more likely to die within 6 months of transplantation, but those with a score of 6 or less are 41 times more likely to survive the first 6 months than are patients with a higher score. Of course, the 950:'0 confidence intervals for all scores are quite wide in f '
Estimation of Relative Risks
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range. For example, the relative risk for a patient with a score of 7 or above has a 950'/0 chance of being as high as 231 times greater or as low as 7.29 times greater than the relative risk for a patient with a score of 6 or less.
Effect of Previous Surgery on Blood Loss
The mean RBC loss for patients with various operations and the comparison with that for patients with no history of prior surgery is shown in Table 7 . Several comparisons were made. A group of 31 patients who had had either bile duct reconstructions, cholecystectomies, or any kind of shunt procedure were compared with the 129 patients who had undergone either no perihepatic surgery or 
DISCUSSION
Perhaps more so than for most surgical procedures, candidates for liver transplantation present in a wide range of physiologic conditions. Although the most important reasons for failure in these patients are still related to rejection, with the introduction of cyclosporine and following major improvements in surgical technique, the overall physiologic condition of the individual patient has assumed an even greater role in influencing the eventual outcome following transplantation. This became partie-'Iarly evident when, in a previous study, we ~mined the overall impact of venous bypass on survival and discovered that, although the probability of surviving to 30 days was markedly improved, by 6 months patients transplanted with the use of bypass no longer appeared to have an advantage over those transplanted without bypass. Further investigation revealed that the bulk of the patients in the bypass group who died between 30 and 180 days could be classified, based on physiologic characteristics that they had before surgery, as belonging to a particularly high-risk category. The major purpose of the current study, then, was to determine whether a scoring system could be developed that would allow easier recognition of those patients for whom the probability of survival, despite all of the recent improvements in immunosuppression and technique, is still unacceptably low. A key to developing the scoring system was the definition of a population of patients for whom death or survival was related more to preoperative condition than to technical failures or failure of the hepatic allograft related to poor procurement, rejection, or surgical erorrs. Restricting the analysis to those patients who had only one liver transplant went a long way toward accomplishing this goal, largely because of an aggressive attitude in the Pittsburgh program toward early retransplantation of patients with a failing graft (see accompanying article "Retransplantation of the Liver" in this issue of Seminars). Other patients were eliminated from consideration solely for the purpose of developing the scoring system. The causes of failure in these patients are no less important to examine. As far as the accuracy of the scoring system is concerned, patients who fail to follow predicted courses may truly represent exceptions that prove the rule. Examination of the causes of failure in these patients may, in fact, reveal lessons ultimately more important than those provided by the scoring system itself. This is because. by and large, the scoring system can only make predictions that most physicians experienced in the field already know to be true.
Nevertheless. some important findings are worth reiterating.
Many patient variables, which in the overall analysis have no significant impact, do make a difference among certain groups. For example, overall, age itself is not a factor that correlates with survi· val. However, patients younger than 25 years of age who otherwise have high scores appear to have an advantage over those who are older. An age over 40 years does not influence the probability of survival in the overall group, or in all of the diagnostic categories, with the exception of cirrhosis. In the latter group. howe\'C!r, t he correlation of poor survival f j with age over 40 year . . . arpear~ to he more related to the coexistence of other risk factors in these older patients than to age itself. The extra I point added to scores for an age o\'er 40 years, then, is largely to account for the obser\'ation that most older patients have had their liver disease for a longer period of time. Ultimately, its inclusion appeared to provide greater score separation of the survivors from nonsurvivors.
The most striking finding of the study is that of all the factors studied, survival at 6 months correlates most strongly with RBe. In a sense, RBC is probably a kind of metric scoring system in itself. This is suggested by the observation that RBC correlates most strongly with those other factors with which survival also correlates, namely, the COMA and MALN scores and serum bilirubin and prothrombin time. At the same time, RBe clearly can play an active role in altering the eventual outcome. This is suggested by the observations that patients with high scores who have low blood losses appear to obtain an advantage over those with high scores and higher blood loss, and all patients, regardless of score, appear to have a lower survival probability if" RBC exceeds 40 units.
In this series of patients, neither RBC nor survival correlated with a history of previous surgery. This was true if one included any history of surgery around the liver, such as a cholecystectomy, open liver biopsy, one or multiple bile duct procedures, or shunt procedures. With one exception, it was also true when the larger group was broken down into smaller groups and individual procedures were considered.
The one exception was the group of six patients who had had portosystemic shunts. Mean blood loss in these six was 70.5 units, but it was accounted for almost entirely by four patients. Three of these four patients died on the operating table. The fourth survived surgery and an operative blood loss of 104 units, but died 4 months later, at home, of an opportunistic infection. Two other patients had RBC less than 20 units and have survived for 9 and 10 months. These last two patients and the other one who survived surgery were all three transplanted using venous bypass, whereas the three who died during surgery were not.
The study makes several other things quite clear. It adds statistical confirmation to notions most surgeons in the field already hold.
1. Patients taken to the operating room in deep coma from chronic liver disease almost never survive. Their score places them on the flat, high-risk portion of the sigmoid curve. If the status of these patients can be improved to the point that they are awa~e and ahk to breath \\11'10111 \ l'lli 1 bll " \ ~IlP port. and if they undergo a Ic,-hni,:ally <,I1WI"h operation with low blood loss d without ~urgical cOf!lplications, then they pro ably begin their recovery period between the flection point .. , perhaps even high up toward the I wer ri .. k portion of the curve. The same holds t e for patients undergoing retransplantation. No e in a deep coma and requiring a second or thir 'liver ha<. survived long term.
The example of the one patient in I '~is series in stage IV coma from acute hepatic neerosl. who survived long term underscores the need to aCl uickly. if at all, in the setting of acute and fUI inant hepatic failure. Long-term support, beyond • few days, of a patient in stage IV coma with an exu coagulopathy, hypoglycemia, and other profou metabolic derangements will seldom result in a SUl cessful outcome. The decision to transplant must be made with little hesitation and a suitable donor found quickly.
2. The negative influence that a history of perihepatic surgery has had in previous reports has become much less important in recent years. The routine use of venous bypass may have had an important role in minimizing the specter of previous surgery.
3. Poor surgical technique or errors in surgical judgment can quickly obliterate the significance of any preoperative scoring system. In "general, patients in better overall physiologic condition will tolerate most complications better than their less resilient counterparts. However, the health of all of these patients is compromised to begin with, and the additional burden of long operative procedures and immunosuppression leaves little room for errors.
4. The improvement in survival correlating with a transplant date later than the spring of 1983 reflects several developments. One is the full-scale use of venous bypass, introduced about 6 weeks before. The other is most likely the creation of a liver transplant team by the anesthesiologists in Pittsburgh and the evolvement of a more uniform and informed approach to the operative management of these patients. 4 ,s Finally. emphasis must be placed on the empirical nature of the scoring system. A much larger population of patients to study might allow .more accurate mathematical description of the rela-'tionship between the variables and the survival probability. In addition, the system may not apply very well to other centers where differences in surgical technique or pre-and postoperative management of patients may drastically alter eventual outcome in some or even all patients. In the final analysis, one of the most exciting prospects of the present study would be to discover that such things really will make a difference.
SUMMARY
A group of 118 adults who underwent primary, orthotopic transplantation of the liver over a 4-year period served as the subjects of a detailed examination of their ability to survive the first 6 months as a function of their preoperative condition. As a result, a scoring system was developed empirically in an attempt to separate very high-risk from relatively low-risk patients. The scoring method is based on the high degree of correlation between survival probability and various patient characteristics. It allows for additional scoring to account for the dramatic effect of operative blood loss on the eventual outcome. The curve that best describes the relationship between patient scores and survival probability is sigmoidal in shape. Many patients will have scores located on the curve between the inflec-393 tion points. They represent a group whose relative risk is difficult to estimate but for whom operative blood loss or the occurrence of surgical complications may prove particularly telling.
